An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial

Dinesh Khanna, Carlo Albera, Aryeh Fischer, +7

The Journal of Rheumatology

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase <scp>II</scp> Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial

Dinesh Khanna, Cathie Spino, Sindhu R. Johnson, +35

Arthritis & Rheumatology

Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

Maureen D. Mayes, Lara Bossini‐Castillo, Olga Y. Gorlova, +115

The American Journal of Human Genetics

Autoimmune DiseaseMedicineImmunologySystemic SclerosisAutoimmunity +4

Trial of Intravenous Immune Globulin in Dermatomyositis

Rohit Aggarwal, Christina Charles‐Schoeman, Joachim Schessl, +26

New England Journal of Medicine

Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry

Robyn T. Domsic, Bharathi Lingala, Firas Alkassab, +21

Arthritis Care & Research

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

Dinesh Khanna, Veronica J. Berrocal, Edward H. Giannini, +21

Arthritis & Rheumatology

Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

Suzanne Kafaja, Philip J. Clements, Holly Wilhalme, +150

American Journal of Respiratory and Critical Care Medicine

Clinical and serological features of systemic sclerosis in a multicenter African American cohort

Nadia D. Morgan, Ami A. Shah, Maureen D. Mayes, +25

Medicine

Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine

Elena Schiopu, Kristine Phillips, Paul M MacDonald, +2

Arthritis Research & Therapy

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

Dinesh Khanna, Yannick Allanore, Christopher P. Denton, +26

Annals of the Rheumatic Diseases